Literature DB >> 27269030

Global Burden Of Disease Studies: Implications For Mental And Substance Use Disorders.

Harvey Whiteford1, Alize Ferrari2, Louisa Degenhardt3.   

Abstract

Global Burden of Disease studies have highlighted mental and substance use disorders as the leading cause of disability globally. Using the studies' findings for policy and planning requires an understanding of how estimates are generated, the required epidemiological data are gathered, disability and premature mortality are defined and counted, and comparative risk assessment for risk-factor analysis is undertaken. The high burden of mental and substance use disorders has increased their priority on the global health agenda, but not enough to prompt concerted action by governments and international agencies. Using Global Burden of Disease estimates in health policy and planning requires combining them with other information such as evidence on the cost-effectiveness of interventions designed to reduce the disorders' burden. Concerted action is required by mental health advocates and policy makers to assemble this evidence, taking into account the health, social, and economic challenges facing each country. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Mental Health/Substance Abuse

Mesh:

Year:  2016        PMID: 27269030     DOI: 10.1377/hlthaff.2016.0082

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  27 in total

1.  Independent and joint association of obesity and metabolic syndrome with depression and inflammation.

Authors:  Kasra Moazzami; Bruno B Lima; Samaah Sullivan; Amit Shah; J Douglas Bremner; Viola Vaccarino
Journal:  Health Psychol       Date:  2019-05-23       Impact factor: 4.267

2.  Association of perceived stress with health status outcomes in patients with peripheral artery disease.

Authors:  Ali O Malik; Kensey Gosch; Merrill B Thomas; Carlos Mena-Hurtado; William Hiatt; Herbert D Aronow; Phillip G Jones; Jeremy Provance; Clementine Labrosciano; Qurat-Ul-Ain Jelani; John A Spertus; Kim G Smolderen
Journal:  J Psychosom Res       Date:  2020-11-24       Impact factor: 3.006

3.  The Association Between Peripheral Oxytocin Levels and Depressive Symptoms in People With HIV.

Authors:  Destin D Shortell; Leah H Rubin; Aidan J Murphy; Ronald A Cohen; Eric C Porges
Journal:  Psychosom Med       Date:  2022-08-16       Impact factor: 3.864

Review 4.  Cannabis Epidemiology: A Selective Review.

Authors:  James C Anthony; Catalina Lopez-Quintero; Omayma Alshaarawy
Journal:  Curr Pharm Des       Date:  2017-01-04       Impact factor: 3.116

5.  Direct medical costs of hospitalisations for mental disorders in Shanghai, China: a time series study.

Authors:  Wenming Chen; Shengnan Wang; Qi Wang; Weibing Wang
Journal:  BMJ Open       Date:  2017-10-30       Impact factor: 2.692

6.  Substance use disorder and associated factors among prisoners in a correctional institution in Jimma, Southwest Ethiopia: a cross-sectional study.

Authors:  Yimenu Yitayih; Mubarek Abera; Eliais Tesfaye; Almaz Mamaru; Matiwos Soboka; Kristina Adorjan
Journal:  BMC Psychiatry       Date:  2018-09-27       Impact factor: 3.630

7.  Mental health in the Americas: an overview of the treatment gap.

Authors:  Robert Kohn; Ali Ahsan Ali; Victor Puac-Polanco; Chantal Figueroa; Victor López-Soto; Kristen Morgan; Sandra Saldivia; Benjamín Vicente
Journal:  Rev Panam Salud Publica       Date:  2018-10-10

8.  The meaning of social support for persons with serious mental illness: A family member perspective.

Authors:  Julie Chronister; Sandra Fitzgerald; Chih-Chin Chou
Journal:  Rehabil Psychol       Date:  2020-12-31

9.  Uncovering the hidden impacts of inequality on mental health: a global study.

Authors:  Shoukai Yu
Journal:  Transl Psychiatry       Date:  2018-05-18       Impact factor: 6.222

10.  Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study.

Authors:  Lian Beijers; Klaas J Wardenaar; Fokko J Bosker; Femke Lamers; Gerard van Grootheest; Marrit K de Boer; Brenda W J H Penninx; Robert A Schoevers
Journal:  Psychol Med       Date:  2018-06-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.